cash position

Costco may distribute a special dividend in 2026 given its $16.2B cash position and 2.75-year distribution pattern, though 50x valuation and tariff risks present headwinds.

Century Casinos reports record Q1 revenue of $137.2M (+5% YoY) with operating earnings surging 65% to $11.8M, though net loss of $16.5M persists.

Syra Health reports first profitable quarter with $241K net income, 22% revenue growth to $2.3M, and 11-point gross margin expansion amid strong population health momentum.

OraSure posts 4% Q1 revenue growth to $27.9M with gross margin expansion to 42.3%, maintaining $177M cash. Two FDA submissions expected midyear clearance with 2027 breakeven guidance.

Berkshire Hathaway CEO Greg Abel signals market concerns amid record $397B cash position. S&P 500 CAPE ratio hits highest level since dot-com bubble.

Berkshire Hathaway transitions to new CEO Greg Abel as stock lags S&P 500 by 31 points, saddled with record $370-380B cash pile amid scarce investment opportunities.

GameStop has amassed $9 billion in cash, signaling major acquisition plans. Investors should wait for CEO Ryan Cohen to clarify targets before buying.

Paul Mueller Q1 2026 net income fell 53% to $2.3M on $66.4M revenue due to project costs, but full-year earnings improved 6.3% to $32.1M with strong $235.6M backlog.

Innospec's Performance Chemicals surged 23%, but Oilfield Services plummeted 40%. Adjusted net income hit $46.3M despite $155.6M pension charge.

Carbios reduced operating expenses €7M in 2025, posted €34.3M net loss, and maintains €59M cash reserves while planning Longlaville project restart and Asia expansion.

Carbios cuts operating losses by €7M in 2025, maintains €59.1M cash position, and pursues Asia expansion through Wankai licensing deal while resuming Longlaville industrial project.

CRISPR Therapeutics holds $2B cash reserves funding gene-therapy expansion, while Casgevy sales accelerate to $116M in 2025.

Inventiva filed 2025 regulatory documents with €99.3M cash on hand, advancing lanifibranor Phase 3 trial for metabolic liver disease treatment.

Rocket Lab stock jumped 5.47% Wednesday after completing a $474M equity offering and receiving a Citizens Bank upgrade to Market Outperform with an $85 price target.

C3.ai shares down 55% over one year following $133M quarterly loss; CEO insider sale adds to concerns despite $621.9M cash position.

$FIX stock surges 54% YTD on AI data center cooling demand, $12B backlog, and 41.7% sales growth. Can it deliver millionaire-level returns?

Highlander Silver completes Bear Creek merger, reports $100M cash, begins drilling at world's largest permitted primary silver project in Peru.

GameStop Q4 revenue fell 14.1% to $1.1B, yet adjusted EPS surged 63% to $0.49. With $9B cash and strategic shift under Cohen, meme stock bet now hinges on acquisition strategy.

Intelligent Protection Management reported Q4 2025 revenue of $6.1M with declining net losses and positive adjusted EBITDA, while completing strategic acquisitions and partnerships.

Olema reported strong trial progress for palazestrant in breast cancer, raised $218.5M, and expects pivotal data in fall 2026.